利用不同机器学习模型预测中轴型脊柱关节炎疾病复发:METEOR-SpA登记研究
该研究基于METEOR-SpA登记数据,开发并外部验证机器学习模型预测中轴型脊柱关节炎(axSpA)患者6个月内疾病复发。最终采用岭逻辑回归模型,内部交叉验证ROC-AUC为0.72,外部验证(GLAS队列)ROC-AUC为0.63,区分度中等至 modest,决策曲线分析显示在低阈值概率下具有 modest 的净临床获益。
要点
- 模型保留8个预测因子:ASDAS(当前和既往)、女性、复发史、附着点炎、英夫利昔单抗暴露、医生整体评估和C反应蛋白。
- 内部交叉验证ROC-AUC为0.72(95%CI 0.70-0.75),平均精度(AP)为0.291(0.245-0.337)。
- 外部验证(GLAS队列)ROC-AUC为0.63(95%CI 0.59-0.68),AP为0.142(0.116-0.171)。
核心结论
- 简化逻辑回归模型对axSpA短期复发风险具有中等内部区分度和 modest 外部区分度,不适用于指导个体抢先治疗调整,但可能支持低风险干预如群体风险分层或更紧密随访。
研究设计与样本
- 研究基于METEOR-SpA登记中接受生物改善病情抗风湿药治疗的axSpA患者,以访视水平进行分析,纳入1167例患者和3865次访视。
- 复发定义为下次6个月评估时ASDAS增加≥0.9(或BASDAI增加≥2),采用患者分组交叉验证进行内部评估,并在Groningen Leeuwarden axSpA队列(GLAS)中进行外部验证。
主要发现
- 618例(52.9%)患者至少有一次访视具有已知复发状态,其中170例(27.5%)经历至少一次复发。
- 最终模型为岭逻辑回归,内部交叉验证ROC-AUC为0.72(95%CI 0.70-0.75),AP为0.291(0.245-0.337),保留8个与复发相关的预测因子。
- 外部验证中ROC-AUC为0.63(95%CI 0.59-0.68),AP为0.142(0.116-0.171),决策曲线分析显示在低阈值概率下具有 modest 的正向净临床获益。
关键数值与推荐
- 复发定义:ASDAS增加≥0.9或BASDAI增加≥2(下次6个月评估时)。
- 模型优化指标为平均精度(AP),以处理类别不平衡。
- 最终模型保留的8个预测因子:ASDAS(当前和既往)、女性性别、复发史、附着点炎、英夫利昔单抗暴露、医生整体评估和C反应蛋白。
临床怎么用
- 该模型不意图指导个体抢先治疗调整,但可能支持低风险干预如群体水平风险分层或更紧密随访,需进一步验证。
局限性
- 外部验证区分度 modest(ROC-AUC 0.63),决策曲线分析仅显示低阈值概率下 modest 净临床获益,模型不宜用于个体治疗决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To develop and externally validate machine learning models for predicting disease flares in axial spondyloarthritis (axSpA) using real-world registry data. METHODS: Patients with axSpA receiving biological disease-modifying antirheumatic drugs in the METEOR-SpA registry were analysed at visit level. Flare was defined as an Axial Spondyloarthritis Disease Activity Score (ASDAS) increase ≥0.9 (or Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) increase ≥2) at the next 6-month assessment. Candidate models utilising routine clinical predictors and minimum-redundancy maximum-relevance variable selection were optimised for average precision (AP) to account for class imbalance, evaluated using patient-grouped cross-validation (CV) and externally validated in the Groningen Leeuwarden AxSpA cohort (GLAS) using discrimination, calibration and decision curve analysis (DCA). RESULTS: After eligibility criteria, 1167 patients and 3865 visits were included from the METEOR-SpA cohort; 618 (52.9%) patients had at least one visit with known flare status. Among them, 170 (27.5%) experienced at least one flare. A ridge logistic regression was selected as the final model with an internal CV receiver operating characteristic plot and area under the curve (ROC-AUC) of 0.72 (95% CI 0.70 to 0.75) and an AP of 0.291 (0.245 to 0.337), retaining eight predictors associated with flare. These were ASDAS (current and previous), female sex, flare history, enthesitis, infliximab exposure, physician global assessment and C reactive protein. In external validation in GLAS, ROC-AUC was 0.63 (95% CI 0.59 to 0.68) and AP 0.142 (0.116 to 0.171). DCA showed a modest positive net clinical benefit at low threshold probabilities. CONCLUSIONS: A reduced logistic-regression model showed moderate internal and modest external discrimination for short-term flare risk in axSpA. While not intended to guide individual pre-emptive therapy modification, the model may support low-risk interventions such as group-level risk stratification or tighter follow-up after further validation.
引用
- D B, V F, S A B, et al. Predicting disease flares in axial spondyloarthritis using different machine learning models in the METEOR-SpA registry. RMD Open. 2026. PMID: 42785958. doi:10.1136/rmdopen-2026-007147
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。